INDIRA PRADO: Open Payments
NPI 1679593503 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 66 payments from 16 companies in 2025. Trend: 2023 $1,444 · 2024 $1,509 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 15 | $262 |
| AstraZeneca Pharmaceuticals LP | 13 | $233 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $83 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Dexcom, Inc. | 3 | $50 |
| PFIZER INC. | 3 | $46 |
| Lilly USA, LLC | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: VERQUVO, AIRSUPRA, JARDIANCE, Kerendia, FARXIGA, XIFAXAN, Dexcom G6 Transmitter, KEVEYIS.
Industry payments across TX — which companies pay providers there.
